BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• Job Trends

  Targanta Therapeutics Announces Corporate Restructuring, Reduces 75% of Workforce

  December 19, 2008

   · 

  4 min read
• Drug Development

  ArQule, Inc. Provides Update on Early-Stage Pipeline

  December 19, 2008

   · 

  1 min read
• Business

  Definitive Agreement with Daiichi Sankyo Co Ltd. Executed, $60 Million Payment Received by ArQule, Inc.

  December 19, 2008

   · 

  3 min read
• Business

  Dynavax Technologies Corporation Ends Deal with Merck & Co., Inc. (JOBS) for Hepatitis B Vaccine

  December 19, 2008

   · 

  4 min read
• FDA

  Antisoma PLC Receives FDA Approval for Oral Fludarabine, Plans Commercialization Deal to Bring Drug to US Patients

  December 19, 2008

   · 

  4 min read
• SkyePharma Inc. Ceases Commercialization of formoterol Certihaler(R) in the United States

  December 19, 2008

   · 

  1 min read
• Business

  Critical Outcome Technologies Inc. Reports Second Quarter 2009 Financial Results

  December 19, 2008

   · 

  5 min read
• BioMidwest

  CytoDyn Launches Feasibility Study in China

  December 19, 2008

   · 

  1 min read
• Bio NC

  etrials Re-Aligns Organization to More Effectively Focus on Key Customer Segments and Capture Future Growth Opportunities

  December 19, 2008

   · 

  1 min read
• Drug Development

  NicOx SA’s Naproxcinod Shows Differentiated 24-Hour Blood Pressure Profile After 13 Weeks Treatment The Results of the 112 Ambulatory Blood Pressure Monitoring (ABPM) Study Complete an Extensive Database in More Than 3,000 Patients

  December 19, 2008

   · 

  8 min read